Lv2
165 积分 2021-08-11 加入
Elucidating the role of pharmacogenetics in irinotecan efficacy and adverse events in metastatic colorectal cancer patients
12天前
已完结
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice
12天前
已完结
Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan
12天前
已完结
Chemotherapy-induced hand-foot syndrome and nail changes: A review of clinical presentation, etiology, pathogenesis, and management
12天前
已完结
Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
13天前
已完结
Myelotoxicity From Chemotherapy
13天前
已完结
Managing Hematologic Toxicities in the Oncology Patient
13天前
已完结
Gastric cancer
1个月前
已完结
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
1个月前
已完结
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
1个月前
已完结
皖公网安备34019202002308
